Market closed

DarioHealth/$DRIO

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About DarioHealth

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

Ticker

$DRIO

Sector

Health Care

Trading on

NASDAQ

Industry

Health Care Technology

Headquarters

New York, United States

Employees

249

Website

www.dariohealth.com

DarioHealth Metrics

BasicAdvanced

$27M

-

-$0.88

1.51 -

Price and volume

Market cap

$27M

Beta

1.51

52-week high

$2.60

52-week low

$0.63

Average daily volume

290K

Financial strength

Current ratio

1.567

Quick ratio

1.257

Long term debt to equity

36.267

Total debt to equity

52.103

Interest coverage (TTM)

-2,406.52%

Management effectiveness

Return on assets (TTM)

-34.74%

Return on equity (TTM)

-74.91%

Valuation

Price to revenue (TTM)

1.253

Price to book

0.42

Price to tangible book (TTM)

-1.29

Price to free cash flow (TTM)

-0.734

Growth

Revenue change (TTM)

-2.09%

Earnings per share change (TTM)

-56.93%

3-year revenue growth (CAGR)

11.64%

3-year earnings per share growth (CAGR)

-39.59%

What the Analysts think about DarioHealth

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for DarioHealth stock.

DarioHealth Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

DarioHealth Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

DarioHealth News

AllArticlesVideos

DarioHealth Expands GLP-1 Weight-Loss Solution, Unlocking New Revenue Streams in Rapidly Growing Multi Billion Dollar Market

Business Wire·17 hours ago

DarioHealth Corp. (DRIO) Q3 2024 Earnings Call Transcript

Seeking Alpha·2 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $DRIO

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for DarioHealth stock?

DarioHealth (DRIO) has a market cap of $27M as of January 15, 2025.

What is the P/E ratio for DarioHealth stock?

The price to earnings (P/E) ratio for DarioHealth (DRIO) stock is 0 as of January 15, 2025.

Does DarioHealth stock pay dividends?

No, DarioHealth (DRIO) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next DarioHealth dividend payment date?

DarioHealth (DRIO) stock does not pay dividends to its shareholders.

What is the beta indicator for DarioHealth?

DarioHealth (DRIO) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.